BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 26, 2024
See today's BioWorld
Home
» ‘Cure, not care’ is the mantra for Japan’s Regimmune
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
‘Cure, not care’ is the mantra for Japan’s Regimmune
March 25, 2014
By
Marie Powers
No Comments
Since launching in Tokyo in 2006, followed by the establishment of a U.S. subsidiary a year later, Regimmune Corp. has endured both financial and natural disasters: the meltdown of the global capital markets and the Tōhoku earthquake and tsunami.
BioWorld